Asia Pacific Enteral and Parenteral Medical Nutrition Market
肠内和肠外医疗营养市场中的公司不断关注战略发展，例如合作、扩张、协议、伙伴关系和新产品发布，这有助于他们提高销售额、扩大地域范围覆盖并增强他们的能力，以满足比现有客户群更大的需求。提到了肠内和肠外医疗营养市场的一些值得注意的发展，例如：2022 年 6 月，雀巢健康科学从 CDH Investments 和 TBHC 创始股东手中收购了 The Better Health Company (TBHC)。此次收购包括 GO Healthy 品牌及其维生素和补充剂系列；麦卢卡蜂蜜品牌埃格蒙特；新西兰健康制造公司是一家位于奥克兰的维生素、矿物质和补充剂制造工厂。此次收购帮助雀巢健康科学加强和扩大了其在新西兰、澳大利亚和其他亚太国家的业务。 2021 年 9 月，雅培为依赖饲管的人们推出了植物蛋白和有机食品成分——PediaSure Harvest 和 Ensure Harvest。收获产品可用作单一来源的营养品或补充剂，以满足日常营养需求。 2020 年 12 月，雅培推出了 Pedialyte Hydration Solution，这是一种采用关键营养素设计的新配方，可支持免疫健康。具有免疫支持功能的 Pedialyte 含有益生元、维生素 B12、维生素 C、维生素 E 和锌，因其在免疫系统的发育和改善中的重要性而经过专门选择。 2020 年 10 月，Nutricia（达能旗下）收购了 Real Food Blends。该公司通过为依赖饲管的儿童和成人带来更多独特和营养的选择，帮助实现真正的食品混合使命和产品组合。因此，推出即饮、即用营养补充剂等产品；开发针对各种健康问题的创新产品；扩张和收购等战略举措使肠内和肠外医疗营养市场的公司能够创造新的或改进的产品和新业务，以保持市场竞争力。因此，此类战略增长举措为市场创造了巨大的增长机会。
亚太地区 (APAC) 是肠内和肠外医疗营养增长最快的区域市场，分为中国、日本、印度、韩国、澳大利亚、印度尼西亚、泰国、越南等亚太地区。促进该地区市场增长的因素是慢性病患病率的上升以及该地区市场参与者的不断增加，从而赋予了肠内和肠道药物最高的产量。肠外营养产品。此外，营养领域的支持性政府举措和研究促进了市场增长。
亚太肠内和肠外医疗营养市场细分
亚太肠内和肠外医疗营养市场细分为适应症、营养类型、形式、产品类型、途径管理、年龄组、分销渠道和国家。
根据适应症，亚太肠内和肠外医疗营养市场细分为老年人、胃肠道疾病、糖尿病、癌症、呼吸系统疾病、阿尔茨海默病、痴呆、肾病、肝功能衰竭、covid-19 后以及其他适应症。 2023年，老年人群在亚太肠内和肠外医疗营养市场中占据最大份额。胃肠道疾病分为IBD、IBS等。
基于营养根据类型，亚太肠内和肠外医疗营养市场分为补充来源和单一来源。 2023年，补充品细分市场在亚太肠内和肠外医疗营养市场中占据较大份额。
根据形式，亚太肠内和肠外医疗营养市场进行细分分为液体、粉末、半固体。 2023年，液体细分市场在亚太肠内和肠外医疗营养市场中占据最大份额。
根据产品类型，亚太肠内和肠外医疗营养市场细分分为一般性和特定疾病。 2023年，普通细分市场在亚太肠内和肠外医疗营养市场中占据最大份额。
根据给药途径，亚太肠内和肠外医疗营养市场为分为口服、管饲和肠胃外。 2023年，肠外细分市场在亚太肠内和肠外医疗营养市场中占据最大份额。
根据年龄组，亚太肠内和肠外医疗营养市场进行细分分为60岁以上、18-60岁、3-18岁、3岁以下。 2023年，60岁以上细分市场占据亚太肠内和肠外医疗营养市场最大份额。
根据分销渠道，亚太肠内和肠外医疗营养市场细分为医院药房、零售店、电子商务等。 2023年，医院药房细分市场在亚太肠内和肠外医疗营养市场中占据最大份额
根据国家/地区，亚太肠内和肠外医疗营养市场细分为：进入中国、日本、印度、澳大利亚、韩国、印度尼西亚、泰国、越南和亚太地区其他地区。 2023年，中国在亚太肠内和肠外医疗营养市场份额中占据主导地位。
雅培实验室； B.布劳恩公司；百特国际公司；费森尤斯·卡比股份公司；雀巢公司；和 Nutricia International BV 是亚太肠内和肠外医疗营养市场的领先公司。
Strategic insights for Asia Pacific Enteral and Parenteral Medical Nutrition involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2,339.32 Million |
| Market Size by 2028 | US$ 3,352.69 Million |
| Global CAGR (2023 - 2028) | 7.5% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By 适应症
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Enteral and Parenteral Medical Nutrition refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Enteral and Parenteral Medical Nutrition Market is valued at US$ 2,339.32 Million in 2023, it is projected to reach US$ 3,352.69 Million by 2028.
As per our report Asia Pacific Enteral and Parenteral Medical Nutrition Market, the market size is valued at US$ 2,339.32 Million in 2023, projecting it to reach US$ 3,352.69 Million by 2028. This translates to a CAGR of approximately 7.5% during the forecast period.
The Asia Pacific Enteral and Parenteral Medical Nutrition Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Enteral and Parenteral Medical Nutrition Market report:
The Asia Pacific Enteral and Parenteral Medical Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Enteral and Parenteral Medical Nutrition Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Enteral and Parenteral Medical Nutrition Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Enteral and Parenteral Medical Nutrition Market
